학술논문
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut ) for the Treatment of NPM1mut -Acute Myeloid Leukemia
Document Type
Article
Author
Source
In: Cancers . (Cancers, May 2023, 15(10))
Subject
Language
English
ISSN
20726694